ABT | tickerfilter.com

Fundamental analysis

45%

Profitability 35%

Dept financing 22%

Liquidity 75%

Performance 54%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-5.14%

1 Month

-9.10%

3 Months

9.29%

6 Months

8.92%

1 Year

12.98%

2 Year

20.41%

Key data

Stock price

$124.86

P/E Ratio

14.56

DAY RANGE

$120.47 - $126.50

EPS

$7.67

52 WEEK RANGE

$99.71 - $141.23

52 WEEK CHANGE

$11.05

MARKET CAP

195.160 B

YIELD

1.96%

SHARES OUTSTANDING

1.740 B

DIVIDEND

$0.55

EX-DIVIDEND DATE

04-15-2025

NEXT EARNINGS DATE

04-16-2025

BETA

0.18

PUBLIC FLOAT

AVERAGE 10 VOLUME

$7,583,590

AVERAGE 30 VOLUME

$7,338,836

Company detail

CEO: Robert B. Ford
Region: US
Website: abbott.com
Employees: 115,000
IPO year: 1983

Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Abbott Laboratories discovers, develops, manufactures, and sells health care products. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases.

ABT - ABBOTT LABORATORIES